Abstract Adult skeletal muscle maintenance and regeneration depend on efficient muscle stem cell (MuSC) functions. The mechanisms coordinating cell cycle with activation, renewal, and differentiation of MuSCs remain poorly understood. Here, we investigated how adult MuSCs are regulated by CDKN1c (p57 kip2 ), a cyclin-dependent kinase inhibitor, using mouse molecular genetics. In the absence of CDKN1c, skeletal muscle repair is severely impaired after injury. We show that CDKN1c is not expressed in quiescent MuSCs, while being induced in activated and proliferating myoblasts and maintained in differentiating myogenic cells. In agreement, isolated Cdkn1c-deficient primary myoblasts display differentiation defects and increased proliferation. We further show that the subcellular localization of CDKN1c is dynamic; while CDKN1c is initially localized to the cytoplasm of activated/proliferating myoblasts, progressive nuclear translocation leads to growth arrest during differentiation. We propose that CDKN1c activity is restricted to differentiating myoblasts by regulated cyto-nuclear relocalization, coordinating the balance between proliferation and growth arrest.
Introduction
Tissue regeneration is of vital importance for restoring tissue structure and function following damage. Skeletal muscle has a remarkable capacity to self-repair after severe injuries, a process dependent on muscle stem cells (MuSCs) (Relaix and Zammit, 2012) . MuSCs originate from a PAX3/7+ progenitor cells that in late fetal life acquire their characteristic anatomical position between the basal lamina and the plasma membrane of muscle fibers (Mauro, 1961; Relaix et al., 2005) . MuSCs are indispensable for postnatal muscle growth (White et al., 2010; Pawlikowski et al., 2015) , maintenance (Keefe et al., 2015; Pawlikowski et al., 2015) , and regeneration upon injury (Lepper et al., 2011; McCarthy et al., 2011; Murphy et al., 2011; Sambasivan et al., 2011) . The majority of juvenile MuSCs acquire a non-proliferative, quiescent state around 3 weeks of post-natal life to ensure cellular/genomic integrity and long-term survival (Lepper et al., 2009; White et al., 2010; Cheung and Rando, 2013) . However, once stimulated by homeostatic demand or damage, adult MuSCs exit quiescence, re-enter the cell cycle, and provide differentiated progeny for muscle repair, while a subpopulation self-renews to preserve the quiescent pool (Relaix and Zammit, 2012) . The myogenic regulatory factors including MYOD and MYOGENIN orchestrate MuSCs commitment and progression through the myogenic lineage (Wang et al., 2014) , while the signals that trigger cell cycle exit and (re-) entry into quiescence remain more elusive.
Cell cycle is a tightly synchronized process responding to positive and negative signals, while inappropriate growth arrest can result in cancer, malformations during development, and defective stem cell renewal (Zhang et al., 1997; Matsumoto et al., 2011; Sherr, 2012) . Cyclin-dependent kinase inhibitors (CDKIs) are negative cell cycle regulators. CDKIs are divided into two structurally and functionally defined families: the INK4 family (including Cdkn2a, Cdkn2b, Cdkn2c, and Cdkn2d) and the Cip/Kip family (including Cdkn1a, Cdkn1b, and Cdkn1c) (Borriello et al., 2011) .
Although members of the Cip/Kip family have been shown to inhibit proliferation and promote differentiation in embryonic muscle or in myoblasts in vitro, their involvement in postnatal MuSC cell cycle regulation is less well documented (Halevy et al., 1995; Reynaud et al., 1999; Zhang et al., 1999; Messina et al., 2005; Chakkalakal et al., 2014; Zalc et al., 2014) . Given the emerging importance of Cdkn1c in stem cell quiescence (Matsumoto et al., 2011; Zou et al., 2011; Furutachi et al., 2013) , we explored its role in adult myogenesis and MuSC-supported regeneration. Using mouse mutants and ex vivo analysis, we provide evidence that Cdkn1c is involved in the early phase following MuSC activation events, with its genetic ablation leading to impaired muscle regeneration associated with decreased differentiation and increased proliferation. We further show that Cdkn1c is not detected in quiescent MuSCs but is induced upon activation and maintained in differentiating myogenic cells. Finally, we show that Cdkn1c subcellular localization is specifically regulated during adult myogenesis, with a progressive cytoplasmic to nuclear translocation as activated myoblasts proceed to differentiation. Our results suggest that muscle stem cells require Cdkn1c activity for the dynamic control of growth arrest during adult myogenesis.
Results

Cdkn1c is required for postnatal myogenesis
Although Cdkn1c loss is generally associated with perinatal death (Yan et al., 1997; Zhang et al., 1997; Susaki et al., 2009; Mademtzoglou et al., 2017) , a few Cdkn1c mutant mice survived in a mixed CD1;B6 background (4.2%; Figure 1 -figure supplement 1A). Cdkn1c-deficient mice displayed reduced body weight compared to control littermates (Figure 1-figure supplement 1B-C). However, there was no significant difference in forelimb grip strength between Cdkn1c mutant and control mice at 1 or 2 months of age when the strength was calculated on a per weight basis. Strength was even slightly higher in 3-or 4-month-old Cdkn1c mutant mice compared to controls ( Figure 1-figure supplement 1D ). This difference could be explained by the smaller body weight of Cdkn1c mutants, possibly leading to increased relative grip strength (N/kg) in mutants. To evaluate the role of CDKN1c in muscle homeostasis, we examined sections of the hindlimb Tibialis anterior (TA) muscles in adult mice. Histological analysis showed that Cdkn1c knock-out muscles contained smaller fibers and displayed increased fibrosis ( Figure 1A-D) , implying hindered myogenic differentiation. The amount of centrally located nuclei, indicative of ongoing regeneration, was comparable in mutants and controls ( Figure 1E ). Myofiber culture conditions used allow MuSCs to become activated, start dividing (T24-48), and eventually, proceed to myogenic differentiation or self-renewal of the quiescent pool (T72) (Zammit et al., 2004) . The number of PAX7+ MuSC on freshly isolated myofibers of Extensor digitorum longus (EDLs) was increased in Cdkn1c mutant mice compared to the controls ( Figure 1F-G) . Furthermore, PAX7+ MuSCs on Cdkn1c mutant myofibers were mostly MYOD-, at a similar percentage to controls ( Figure 1H ), indicating that Cdkn1c is not regulating MuSCs quiescence. When single myofibers were cultured for 72 hr (T72), Cdkn1c mutants displayed an increased ratio of PAX7+ MYOD-self-renewing cells and a decreased ratio of PAX7-MYOD+ differentiating myoblasts ( Figure 1I-J) . Taken together, our data suggest that in the absence of CDKN1c the MuSC compartment is correctly established, but a proportion of the MuSC population undergo increased self-renewal at the expense of differentiation.
Next, we evaluated the impact of CDKN1c loss on skeletal muscle regeneration. We performed intramuscular cardiotoxin (CTX) injections into the Tibialis anterior (TA) and sacrificed the mice at 3, (d3), 4 (d4), 7 (d7), and thirty (d30) days post-injury, to evaluate early and late time points of the regeneration procedure. Once muscle degeneration is induced, MuSCs undergo: (1) activation, (2) proliferation to expand their population, (3) self-renewal of the quiescent pool for future needs, and (4) differentiation for newly generated fibers and muscle repair (Relaix and Zammit, 2012) . At d3 post-injury, loss of Cdkn1c promoted myoblasts proliferation and counteracted differentiation, as shown by increased EdU+ incorporation and reduced MYOD+EdU+ fraction, respectively. (Figure 2-figure supplement 1A,B) . At d4 post-injury, Cdkn1c-deficient muscles showed smaller embryonic myosin (eMyHC)+ myofibers, a marker for early myofiber formation, compared to controls ( Figure 2A,C) . At d7 post-injury, Cdkn1c-deficient muscles showed increased cell infiltration and smaller and heterogeneous myofiber formation ( Figure 2A ,B,D), suggesting a delay in the regeneration process. At d30, signs of impaired regeneration associated with smaller fibers were observed ( Figure 2A ,B,E), including deposition of fibrotic tissue ( Figure 2A ,F) in Cdkn1c-mutant mice. Next, we evaluated the MuSC population from isolated myofibers of EDLs at d30 and TA muscle sections. The number of PAX7+ MuSCs was increased in Cdkn1c mutants compared to the controls ( Figure 2I ). Therefore, our data suggest that Cdkn1c is required for postnatal muscle repair. In addition, Cdkn1c mutant myogenic cells demonstrated increased propensity for stem-cell self-renewal during both tissue establishment and regeneration.
CDKN1c regulates the balance between proliferation and differentiation in activated myoblasts
We next abrogated CDKN1c specifically in adult MuSC to avoid cell non-autonomous effects and bypass the impact of CDKN1c loss during development. To conditionally ablate Cdkn1c, we have generated a floxed Cdkn1c allele (Cdkn1c Flox ) to enable conditional knock-out of Cdkn1c using the Cre/loxP system (Mademtzoglou et al., 2017) . Given that Cdkn1c is an imprinted gene expressed only by the maternal allele (Matsuoka et al., 1995) , we used heterozygotes with maternal inheritance of Cdkn1c Flox , hereafter indicated as Cdkn1c Flox(m)/+ . To specifically target the MuSCs and their progeny, we intercrossed Cdkn1c Flox mice with the Pax7 CreERT2 line (Lepper et al., 2009 ). In the compound mice, tamoxifen (TMX) administration results in CreERT2 translocation to the nucleus and Cdkn1c excision in the MuSC lineage. One week of TMX administration led to 84.5% recombination efficiency (Figure 3 -figure supplement 1A-B). We then inserted Cdkn1c Flox and Pax7
CreERT2 in the ROSA mTmG background (Muzumdar et al., 2007) . These double-fluorescent mice report Cre activity by expressing membrane-Tomato (mT) prior to Cre-mediated excision and membrane-GFP (mG) after excision. This allowed us to selectively isolate recombined (GFP+) MuSC cells. We isolated by flow cytometry GFP+ MuSCs of control (Pax7 CreERT2 ; Cdkn1c +/+ ; ROSA mTmG/+ ) and Cdkn1c-deficient (Pax7 CreERT2 ; Cdkn1c Flox(m)/+ ; ROSA mTmG/+ ) mice. Collected cells grew in expansion conditions (20% fetal bovine serum, 10% horse serum) up to 70% confluence and then were serum-deprived to differentiate for 1 or 3 days ( Figure 3A) . Cdkn1c transcript and protein were induced by differentiation in control cells ( Figure 3B-C) . In contrast, they were not detected in cells from mutant animals ( Figure 3B,D) , demonstrating efficient Cre-mediated recombination of the Cdkn1c allele in FACS-isolated cells. We then performed primary myoblast cultures from control and Cdkn1c-deficient mice. We monitored proliferating cells under 'growth' (high serum) or 'differentiation' (low serum) conditions, and at d1 and d3 post-differentiation we stained with early (e.g. MYO-GENIN) or late (i.e. Myosin heavy chain, MyHC) differentiation markers, respectively. Consistent with the function of CDKN1cas a cell cycle inhibitor, we observed increased proliferation in primary Figure 3-figure supplement 1C-F) . Furthermore, in cultures of FACS-isolated MuSCs from MuSC-specific Cdkn1c-deficient mice, myogenic differentiation was impaired. One-day postdifferentiation, MYOGENIN was significantly decreased ( Figure 3I ,K,L). In addition, myotube formation 3 days post-differentiation was severely compromised ( Figure 3J ,M,N). We also detected a similar increase in cell proliferation and reduction in myogenic differentiation in primary myoblasts isolated from global Cdkn1c mutant mice (Figure 3-figure supplement 2). In conclusion, both MuSC-specific and global ablation of CDKN1c led to increased primary myoblasts proliferation at the expense of myogenic differentiation. Together, our data demonstrate that CDKN1c is required in MuSCs for correct cell cycle regulation and differentiation during postnatal myogenesis.
Satellite-cell-specific CDKN1c loss compromises muscle regeneration
We next evaluated the impact of MuSC-specific Cdkn1c ablation, driven by Pax7 
Dynamic CDKN1c expression in adult myogenesis
To analyze the expression of CDKN1c during MuSC-mediated myogenesis, we isolated single myofibers with their associated PAX7+ MuSCs from EDL muscles of adult wild-type mice. Immunostaining experiments, using a CDKN1c-specific antibody, showed that quiescent MuSCs were not labeled ( myoblasts at T24-T48 presented with increasing amounts of CDKN1c. Unexpectedly, this negative cell cycle regulator was not expressed in the quiescent population, but in activated MuSCs entering the cell cycle. However, during this early proliferation phase, CDKN1c was restricted to the cytoplasm ( Figures 5A-B and 6A-B). Consistent with these findings, CDKN1c was mainly restricted to the cytoplasm at d3 following CTX injection in vivo, a time point when most cells are in a proliferative state ( Figure 5C ). At T72, clusters composed of cells at different states are observed, including differentiation (loss of PAX7 expression associated with expression of MYOD and MYOGENIN) and self-renewal (maintenance of PAX7, loss of MYOD, and lack of MYOGENIN) (Zammit et al., 2004) . Thus, there is a mixed population of self-renewing (cells expressing PAX7 alone), activated/proliferating (cells co-expressing PAX7 and MYOD), and differentiating (cells expressing MYOGENIN and/or MYOD) myogenic cells. At this stage, we observed high percentages of CDKN1c expression in each of these populations ( Figure 6A-C) . Interestingly, as differentiation proceeded (MYOD+ followed by MYOGENIN +at T72), Cdkn1c expression became increasingly nuclear ( Figure 6B -C). Although Cdkn1c was mostly cytoplasmic in PAX7+/Cdkn1c + T72 myoblasts, Cdkn1c exhibited nuclear presence in around 25% of MYOD+/Cdkn1c+ and 55% of MYOGENIN+/Cdkn1c + T72 myoblasts ( Figure 6A-C) . In line with this, Cdkn1c protein was mainly restricted to cell nuclei at late stages of regeneration following in vivo muscle injury (d13 post-CTX; Figure 5C ). Finally, similarly to the T24-T48 activated/cycling populations of myoblasts in single myofibers ex vivo, Cdkn1c continued to be present in KI67+ proliferating cells at T72, yet limited to their cytoplasm ( Figure 6D) . Next, to evaluate whether Cdkn1c nuclear translocation was linked with its association with MYOD (Reynaud et al., 2000; Vaccarello et al., 2006; Figliola et al., 2008; Osborn et al., 2011; Busanello et al., 2012; Battistelli et al., 2014; Zalc et al., 2014) , we used data generated by a MYOD ChIP sequencing experiment (Cao et al., 2010) to identify MYOD-binding sites at muscle regulatory regions. We performed ChIP experiments with an anti-Cdkn1c antibody to test whether Cdkn1c shares these binding sites with MYOD, and we found no significant enrichment at any of the tested sites ( Figure 6-figure supplement 1) .
Finally, to establish whether the subcellular localization of CDKN1c directly affects the cycling status of myoblasts, we generated retroviruses encoding full-length Cdkn1c (Cdkn1c FL) or Cdkn1c lacking the Nuclear localization signal (Cdkn1c -NLS), using Cyan fluorescence protein (CFP) as a reporter to identify transduced cells ( Figure 6E) . A mock CFP retrovirus was used as control ( Figure 6E-F) . Overexpression of Cdkn1c FL in single myofiber cultures was associated with nuclear CDKN1c protein ( Figure 6E ) and a marked decrease in cycling myoblasts ( Figure 6E,F) . In contrast, forced expression of the NLS-deficient construct restricted CDKN1c to the cytoplasm ( Figure 6E ) and did not induce cell cycle exit as Cdkn1c FL ( Figure 6E,F) . By contrast, overexpression of either Cdkn1c FL or Cdkn1c -NLS did not alter the proportions of cells entering myogenic differentiation, as evidenced by MYOD and/or MYOGENIN expression ( Figure 6-figure supplement 2A-D) . Lastly, in order to eliminate potential interference with endogenous Cdkn1cCDKN1c in these experiments, we repeated them in Cdkn1c-deficient myoblasts following FACS isolation ( Figure 6-figure  supplement 2E ). Comparably to the ex vivo system of single myofibers ( Figure 6E, Figure 6 - figure  supplement 2A-D) , we observed cell cycle exit, uncoupled from myogenic differentiation, in Cdkn1c FL but not Cdkn1c -NLS (Figure 6-figure supplement 2E-G) . Together, these results show that nuclear CDKN1c promotes growth arrest, while cytoplasmic localization of the protein -observed at early stages of MuSC activation -is compatible with proliferation. Furthermore, our data suggest uncoupling of cell cycle exit and myogenic differentiation. 
Discussion
Regenerative adult myogenesis is crucial for recovery from injuries, but can be compromised by degenerative or disease states that affect the functional capacity of skeletal muscle stem cells (MuSC). The maintenance of MuSC function largely depends on the entry and maintenance of a noncycling, reversible quiescent state. The molecular mechanisms that control MuSC cell cycle transitions and adult myogenesis have gained significant interest in recent years, as a way to understand post-trauma tissue restoration and, subsequently, to design efficient innovative therapies when it is defective.
Focusing on cell cycle exit signals and given our recent findings on the role of CDKN1c in cell fate decisions in embryonic/fetal myogenesis (Zalc et al., 2014) , we hypothesized that CDKN1c may control cell cycle and differentiation of MuSCs in adult muscle. Indeed, Cdkn1c deficiency compromised muscle regeneration following in vivo injury (Figure 2A-D; Figure 4 ) and hindered primary myoblast differentiation and myotube formation (Figure 3; Figure 3-figure supplement 2) . CDKN1c expression correlates with differentiation in many other cell types (Westbury et al., 2001) , while in myogenic cultures CDKN1c has also been considered as a differentiation marker (Reynaud et al., 1999; Mounier et al., 2011) . Nevertheless, the consequences of its ablation on adult muscle have not been examined previously, notably because of the perinatal lethality of Cdkn1c mutant mice. Maintaining the mice in a mixed CD1;B6 background allowed us to obtain some survivors, while analyzing floxed Cdkn1c mice allowed cell-specific studies. In vivo and in vitro analysis of both models demonstrated that lack of Cdkn1c compromised myogenic differentiation (Figures 1-4, Figure 3 -figure supplement 2). In the case of Cdkn1c-null mice, there was increased MuSC self-renewal at the expense of differentiation (Figures 1-2) , while conditional deletion of Cdkn1c in adult mice diminished the MuSC compartment after injury (Figure 4) . These seemingly contradictory results might depend on compensatory mechanisms that are activated when Cdnk1c deletion is induced prenatally (mutant) versus postnatally (cKO). Moreover, in our cKO mice, compounding effects of inactivating both Pax7 (due to CreERT2 insertion in the PAX7 locus) and Cdkn1c cannot be excluded. However, comparing the Cdkn1c cKO mice to the Cre control, showed a much more severe regeneration impairment in the former (Figure 4) . Together, our data on Cdkn1c mutant and cKO mice implicate an important function for CDKN1c in adult myogenesis, similarly to its emerging importance in the quiescence and renewal of several other stem cell types [Matsumoto et a., 2011; Zacharek et al., 2011; Furutachi et al., 2013) .
Examining the myoblast populations expressing CDKN1c (i.e. quiescent vs. activated), we did not detect CDKN1c in quiescent MuSCs on sections or isolated myofibers of resting adult (8-12 weeks) muscle ( Figure 5-figure supplement 1) . On the contrary, CDKN1c was readily detected in interstitial cells ( Figure 5-figure supplement 1) . Our finding is consistent with previous reports of high CDKN1c levels in adult muscle (Matsuoka et al., 1995; Park and Chung, 2001 ) and lack of CDKN1c in FACS-isolated postnatal MuSC populations (Chakkalakal et al., 2014) or myofiber-associated MuSCs (Naito et al., 2016) . In contrast, an early study detected CDKN1c in quiescent MuSCs (Fukada et al., 2007) which were isolated with a FACS protocol using an antibody previously described by the same group (Fukada et al., 2004) . However, this antibody immuno-reacts with bone marrow cells (Fukada et al., 2004) , while CDKN1c has a well-established role and presence in the hematopoietic lineage (Matsumoto et al., 2011; Zou et al., 2011) . Furthermore, CDKN1c immunostaining in Fukada et al. (2007) was performed with an antibody against the CDKN1c carboxy-terminus, which might cross-react with the respective domain of CDKN1b (Matsuoka et al., 1995; Galea et al., 2008; Pateras et al., 2009 ). Combining our observation with previous reports (Fukada et al., 2004; Fukada et al., 2007; Chakkalakal et al., 2014; Naito et al., 2016) ; present study], we conclude that quiescent MuSCs do not express CDKN1c. Instead, it is established that they express CDKN1b, another member of the CDKI family including CDKN1c (Chakkalakal et al., 2014) ; our unpublished data].
Upon MuSC activation and differentiation, we show that CDKN1c is strongly upregulated (Figures 5-6) . Accordingly, activation of MuSCs during muscle regeneration has been shown to induce CDKN1c, with its levels peaking at d3-4 (Yan et al., 2003) ; our unpublished observations]. The early induction of CDKN1c upon activation might be associated with MYOD expression, a transcription factor with which CDKN1c has been implicated in a positive feedback loop (Reynaud et al., 2000; Osborn et al., 2011) . Specifically, MYOD has been shown to induce Cdkn1c both by disrupting a chromatin loop to release the Cdkn1c promoter and by upregulating intermediate factors (Vaccarello et al., 2006; Figliola et al., 2008; Busanello et al., 2012; Battistelli et al., 2014) . Furthermore, we previously identified a muscle-specific Cdkn1c regulatory element that MYOD binds and transactivates (Zalc et al., 2014) , while co-immunoprecipitation assays revealed direct CDKN1c-MYOD binding (Reynaud et al., 2000) . Moreover, MyoD mutant mice present a similar muscle phenotype as our Cdkn1c-deficient mice (Megeney et al., 1996) , also consistent with Cdkn1c being a direct downstream gene of MYOD, and possible association of MYOD and CDKN1c. MYOD is expressed within hours after MuSC activation (Zammit et al., 2004; Zhang et al., 2010) and sustains the transition from quiescence to cell cycle via the replication-related factor CDC6 (Zhang et al., 2010) . MYOD induces growth arrest in non-myogenic cell lines (Crescenzi et al., 1990; Sorrentino et al., 1990 ) and has a well-established role for entry into the myogenic lineage. While the possibility of CDKN1c associating with MYOD to regulate CDKN1c translocation was an attractive hypothesis, CDKN1c was not found associated with MYOD binding in muscle-specific gene regulatory regions (Cao et al., 2010 ) evaluated by ChIP (Figure 6-figure supplement 1) . Remarkably, despite robust expression of MYOD, myoblasts continue to proliferate and do not proceed to differentiation for several days (Tajbakhsh, 2009) . In fact, in dividing myoblasts MYOD activity is inhibited by Id proteins and CDK/Cyclin complexes (Wei and Paterson, 2001) . Furthermore, additional factors, including MYOGENIN, were suggested to initiate or enhance transcription of some MYOD targets (Blais et al., 2005; Cao et al., 2006) .
We demonstrate robust CDKN1c presence in activated MuSCs, including expression in proliferating myoblasts in isolated myofiber cultures (e.g. KI67+ cells at T72, cycling cells at T24-T48; Figures 5-6 ). These observations might contradict its traditional function as cell cycle exit factor (Lee et al., 1995; Matsuoka et al., 1995) and its role in growth arrest during embryonic myogenesis (Zhang et al., 1999; Zalc et al., 2014) . Our data, however, suggest that the uncoupling of CDKN1c growth arrest activity in proliferating myoblasts of isolated myofiber cultures is related to its subcellular localization. CDKN1c is cytoplasmically restricted in activated myoblasts but is progressively detected in the nucleus as differentiation takes place ( Figure 6 ). Indeed, forced CDKN1c expression in myoblasts of isolated myofiber cultures led to nuclear CDKN1c and growth arrest, while overexpression of Nuclear localization signal-deficient CDKN1c was compatible with myoblast proliferation (Figure 6 ; Figure 6-figure supplement 2) . On the contrary, CDKN1c cyto-nuclear shuttling was not related to myogenic differentiation, suggesting an uncoupling of cell cycle exit and myogenic differentiation ( Figure 6-figure supplement 2 ), in line with our previous observations in embryonic muscles (Zalc et al., 2014) .
We have not identified the molecular events underlying the CDKN1c nucleo-cytoplasmic shuttling, although some observations might explain this pattern. Firstly, CDKN1c could be implicated in cell cycle progression through CDK/Cyclin assembly, similarly to its Cip/Kip siblings (Michieli et al., 1994; Harper et al., 1995; LaBaer et al., 1997; Peschiaroli et al., 2002) . In the absence of CDKN1a and CDKN1b, CDKN1c is solely responsible for CDK/Cyclin complex stabilization in mouse embryonic fibroblasts (Cerqueira et al., 2014) . However, this might be less likely in myoblasts, where Cdkn1c-MYOD binding engages the CDKN1c helix domain (Reynaud et al., 2000) that was found indispensable for CDK/Cyclin binding and inhibition (Hashimoto et al., 1998; Reynaud et al., 2000) . Moreover, in agreement with CDKN1c function as a cell cycle inhibitor, we observed reduced differentiation and increased proliferation in its absence ( Figures 1I-J, 2A-E and 3E-N) . Secondly, CDKN1c could be involved in nucleo-cytoplasmic distribution of cyclins or CDKs, as previously observed in other cell types. CDKN1c has been shown to interfere with the nuclear translocation of cyclin D1 (Zou et al., 2011) and to relocalize a fraction of CDK2 into the cytoplasm (Figliola and Maione, 2004) . Thirdly, while in the cytoplasm, CDKN1c might participate in MuSC mobilization, one of the earliest manifestations of their activation (Siegel et al., 2009 ). Cytoplasmic CDKN1c was described to regulate cell motility together with LIM-kinase1 (Vlachos and Joseph, 2009; Chow et al., 2011; Guo et al., 2015) . Although we did not detect LIM-kinase1 in myogenic cells, we cannot exclude association with other, yet uncharacterized, partners. Future studies are expected to elucidate the roles of CDKN1c in different sub-cellular compartments of myoblasts.
In conclusion, our data indicate that CDKN1c plays essential roles at the initial phase following MuSC activation. We suggest that CDKN1c acts at that early phase, as a) in vivo, Cdkn1c mutants display a strong phenotype during the first days after injury and b) Cdkn1c mutant myoblasts have compromised functions in cultures that last a few days, thus resembling the first events after MuSC activation. CDKN1c presence is compatible with activation/proliferation and possibly represents an early activation event. Its loss profoundly affects ex vivo myogenic differentiation and delays in vivo post-injury recovery, which may lead to increased MuSC self-renewal. Therefore, the reduced regeneration capacity of Cdkn1c-mutant muscle is not caused by decreased numbers of MuSCs, but results from the reduction of myogenic differentiation, which increases propensity for stem-cell selfrenewal. Defective stem cell cycle dynamics and continuous activation/proliferation can lead to DNA damage accumulation, apoptosis, pool exhaustion, and inability to support homeostatic or regenerative demands. A better understanding of cell cycle regulation in MuSCs is imperative to define the molecular events underlying their long-term preservation. 
Materials and methods
Key resources table
Mouse lines
The following mouse lines have been previously described: Pax7 CreERT2/+ (Lepper et al., 2009 ), Rosa mTmG (The Jackson Laboratory, stock 007576), Cdkn1c cKO (m)/+ (Cdkn1c is imprinted with preferential expression of the maternal allele; superscript (m) indicates maternal inheritance) (Mademtzoglou et al., 2017) , Cdkn1c +/- (Zhang et al., 1997 
Single myofiber isolation and culture
Single muscle fibers were isolated by enzymatic digestion and mechanical disruption of EDL muscles (Moyle and Zammit, 2014) . For enzymatic digestion, muscles were incubated for 90 min at 37˚C with 0.2% collagenase type I (C0130, Sigma-Aldrich) in Penicillin/Streptomycin(P/S)-supplemented DMEM (41966, ThermoFisher Scientific). For mechanical disruption, muscles were transferred to 5%-horse-serum-coated deep petri dishes (Z692301, Sigma-Aldrich) with P/S-supplemented DMEM and medium was flushed against the muscle. Detached fibers were transferred into new dishes with P/Ssupplemented DMEM. For timed culture, all fibers were transferred after finishing isolation into 5%-horse-serum-coated six-well plates and cultured in the presence of 10% horse serum and 0.5% chicken embryo extract (#092850145, MP Biomedicals). Single myofibers for Figure 
Retroviral cloning and infection
Cdkn1c cDNA was cloned by PCR from mouse cDNA and subcloned in the pGEMT-Easy vector (#A1360, Promega). An additional primer was also designed to produce Cdkn1c cDNA lacking the NLS and following sequences (Lee et al., 1995) . Full-length or -NLS Cdkn1c were subsequently subcloned -using XhoI and EcoRI added to cloning primers-into the MISSINCK retroviral production vector, which was based on the pMSCV-IRES-eGFP (MIG) vector (Pear et al., 1998) , substituting eGFP with an insulin signal sequence-Cyan Fluorescent Protein (CFP)-KDEL sequence in order to restrict fluorescent tracker expression to the endoplasmic reticulum and Golgi (Alonso-Martin et al., 2016) . MISSINCK retroviruses expressing either full-length or -NLS Cdkn1c were produced in 293T (DSMZ, #ACC635) cells, and retroviral supernatant was acquired 50 hr post-transfection of 293 T cells. For transduction, single myofiber cultures were incubated with 1:10 diluted retroviral supernatant from 24 to 72 hr after fiber isolation ( Figure 6E ; Figure 6 -figure supplement 2A-D) and primary myoblasts were incubated with 1:10 diluted retroviral supernatant from 48 to 120 hr after FACS isolation ( Figure 6 -figure supplement 2E-G).
Cell sorting and culture
Using the tamoxifen-inducible Cre line Pax7 CreERT2 , membrane-GFP is expressed in muscle satellite cells (MuSCs) of Pax7 CreERT2 ; Rosa mTmG mice. Hindlimb muscles were dissociated by 0.2% w/v collagenase A (11088793001, Roche) and 2.4 U/ml dispase II (04942078001, Roche) in digestion buffer [HBSS (14025, Thermo Scientific), 1% Penicillin/Streptomycin, 10 ng/ml DNase I (11284932001, Sigma), 0.4 mM CaCl 2 , 5 mM MgCl 2 , 0.2% bovine serum albumin (BSA; 0010001620, Jackson ImmunoResearch)] with 90 min incubation at 37˚C. Dissociated muscles were filtered through 100 mm and 40 mm cell strainers. GFP +cells were collected based on gating of GFP signal. Sorted cells were plated on matrigel (354230, Corning Life Sciences)-coated chamber slides (177445, Nalge Nunc International). They were initially cultured in high-serum conditions (referred to as 'growth phase') with 20% fetal bovine serum, 10% horse serum and 1:4000 bFGF (20 ng/ml; 450-33B, PeproTech) in DMEM + Glutamax (61965, ThermoFisher Scientific) supplemented with 1% P/S, 20 mM L-glutamine (25030, Thermo Scientific), 10 mM pyruvate (11360, Thermo Scientific), and 0.1M Hepes (15630, Thermo Scientific). Upon reaching 70% confluence at 5 days post-plating, they were switched to low-serum conditions (5% horse serum in P/S-supplemented DMEM + Glutamax) to differentiate (referred to as 'differentiation phase'). EdU (2 mM; C10340, Thermo Fisher Scientific) chase was performed for 2 hr. EdU-incorporating cells were detected according to the manufacturer's protocol.
Myoblast culture
Hindlimb muscle of control or Cdkn1c mutant mice was harvested for isolation of MuSC-derived primary myoblasts as described previously (Asakura et al., 2001; Motohashi et al., 2014) . Briefly, muscle was dissected, minced and then digested in type I collagenase (Worthington Biochemical Corp.). The dissociated cells were filtered, and incubated with anti-CD45-PE, anti-Sca-1-PE, and anti-CD31-PE antibodies (all from eBiosciences) and integrin a-biotin antibody (Miltenyi Biotec) followed by anti-PE beads (Miltenyi Biotec). For magnetic-activated cell sorting (MACS), LD column (Miltenyi Biotec) was used for negative selection to remove non-muscle cells. Flow-through fraction was used for incubation with anti-biotin beads (Miltenyi Biotec) followed by MS column (Miltenyi Biotec). Enriched MuSCs were fractionated as a positive fraction. MuSC-derived primary myoblasts were cultured in growth media, F-10 Ham's media supplemented with 20% FBS, 20 ng/ml basic fibroblast growth factor (Invitrogen) and 1% penicillin-streptomycin (Gibco) on culture dishes coated with collagen (BD Biosciences), and the growth medium was changed every two days. Procedures for EdU experiments and myogenic differentiation were described above.
Gene expression analysis
RNA was extracted with the RNeasy Micro kit (74004, Qiagen), according to the manufacturer's instructions. cDNA was synthetized with the Transcriptor First Strand cDNA Synthesis kit (04379012001, Roche). RT-qPCR reactions were carried out in triplicate using the LightCycler 480 SyBR Green I Master (04887352001, Roche). Hypoxanthine Phosphoribosyltransferase 1 (HPRT) transcripts were used for normalization. Oligonucleotides sequences were AGGGCATATCCAACAA-CAAACTT and GTTAAGCAGTACAGCCCCAAA for HPRT and CTGAAGGACCAGCCTCTCTC and AAGAAGTCGTTCGCATTGGC for Cdkn1c.
C2C12 culture and ChIP-qPCR C2C12 (PMID: 28966089) cells were grown in DMEM High Glucose (#41966, Life Technologies) supplemented with 10% SVF (Eurobio) until reaching 70% confluence and then they were changed to low serum (2% SVF), differentiation, conditions for four days. Cells were collected and processed for ChIP with the iDeal ChIP-seq kit (C01010051, Diagenode) according to manufacturer's instructions. 1 mg of a mouse anti-Cdkn1c (sc56341, Santa Cruz) or IgG negative control (C15410206, Diagenode) was used. The precipitated and input chromatins were analyzed by qPCR. Primer sequences are listed in Table 1 .
Muscle regeneration
Adult (12-to 15-week-old) mice in Figure 2 and Figure 2 -figure supplement 1 were intramuscularly injected with 70 ml of 10 mM cardiotoxin (CTX) solution (Sigma-Aldrich) into the Tibialis Anterior (TA) after being anesthetized by i.p. injection of Avertin (Sigma-Aldrich) (Asakura et al., 2002) . Muscles were recovered 3, 4, 7 or 30 days post-injury. Five mg/kg of EdU was injected at 24 hr before sacrifice for EdU staining.
Adult (8-to 12-week old) mice in Figure 4 and Figure 5C were intramuscularly injected with 45 ul of 10 mM CTX (Latoxan) into the TA after being anesthetized by i.p. injection of ketamine-xylasin. Muscles were recovered at 3, 7 or 13 days post-injury.
Grip strength test
The maximum grip strength using a grip strength meter (Columbus Instruments) was determined by taking the average of the three highest values out of the 15 values collected and normalized by body weight (Aartsma-Rus and van Putten, 2014). We performed three sets of five consecutive measurements for one set, and mice were allowed to rest for at least 20 min between the sets.
Immunohistochemistry
Sections: Muscles were frozen fresh in liquid nitrogen-cooled isopentane and sectioned at 8 mm. Frozen sections were fixed with 4% paraformaldehyde/PBS for 20 min at room temperature. For hematoxylin-eosin staining, nuclei were stained with hematoxylin (Sigma-Aldrich) for 11 min and cytoplasmes were counter-stained with eosin (Sigma-Aldrich) for 30 s. The sections were then dehydrated with brief passages through increasing concentrations of ethanol (30%, 50%, 70%, 85%, 95%, 100%). Sirius red staining (Sigma-Aldrich) was performed for detection of fibrosis as described previously (Shimizu- Motohashi et al., 2015) . For two-color immunofluorescence, frozen sections were permeabilized with 0.2% Triton X (Sigma-Aldrich) and blocked with M.O.M kit (Vector laboratories) followed by 2% bovine serum albumin (Sigma-Aldrich) at room temperature. For three-color immunofluorescence, sections were permeabilized and blocked with 3% BSA, 10% lamb serum, 0.25% TritonX-100/PBS for 30 min at room temperature. In both cases, immunolabeling was performed at 4˚C overnight for primary antibodies and at room temperature for 1 hr for secondary antibodies. To outline fibers with Alexa-conjugated anti-laminin, incubation was performed for 3 hr at room temperature, after washing out the secondary antibody. Nuclei were counterstained blue with DAPI. When mouse-raised antibodies were applied, endogenous mouse IgG was blocked by incubation with goat anti-mouse fab fragment affinity-purified antibody (115-007-003, Jackson Immunoresearch) for 30 min at room temperature.
Single myofibers: After isolation (T0) or following culture (T24, T48, T72), myofibers were fixed with 37˚C-preheated 4% paraformaldehyde/PBS for 10 min at room temperature. Fixed fibers were permeabilized with 0.5% TritonX-100/PBS for 8 min, blocked with 10% goat serum, 10% swine serum in 0.025% Tween20/PBS for 45 min and incubated with primary antibody (overnight at 4˚C) and secondary antibody (1 hr at room temperature). Nuclei were counterstained blue with DAPI.
Primary myoblast culture: Cell cultures were fixed with 4% paraformaldehyde/PBS for 15 min at room temperature, permeabilized with 0.5% TritonX-100/PBS for 5 min, blocked with 5% BSA, 10% goat serum and immunolabeled with primary antibody (overnight at 4˚C) and secondary antibody (1 hr at room temperature). Nuclei were counterstained blue with DAPI.
Antibodies
The following antibodies were used: chicken anti-GFP 1:1000 (#ab13970, Abcam), mouse anti-KI67 1:80 (#556003, BD Pharmingen), mouse anti-MYOD 1:80 (M3512, DAKO), rabbit anti-MYOD 1:1000 (sc304, Santa Cruz), mouse anti-MYOGENIN 1:100 (F5D-c, DSHB), mouse anti-embryonic MyHC 1:50 (F1.652, DSHB), mouse anti-embryonic MyHC 1:300 (sc53091, Santa Cruz), mouse anti-MyHC 1:100 (mf20-c, DSHB), rabbit AlexaFluor647-conjugated anti-laminin 1:200 (NB300-144AF647, Novus Biological), rabbit anti-laminin 1:400 (L9393, Sigma Aldrich), rat anti-laminin 1:1000 (4H8-2, SigmaAldrich), mouse anti-PAX7 1:100 (Pax7-c, DSHB), rabbit anti-CDKN1c 1:100 (sc8298, Santa Cruz), goat anti-CDKN1c 1:50 (sc1039, Santa Cruz), AlexaFluor-coupled secondary antibodies (Life Technologies, Jackson ImmunoResearch).
Graphic editing
Graphs and representative photos were arranged in Figure format with the graphics editor Photoshop CS5. Curves were adjusted in some photos with identical adjustments between control and experimental samples. Color intensities of hematoxylin-eosin photos were adjusted to acquire uniform result among different sections.
Statistical test
Data of control and mutant mice were compared with the Mann-Whitney U-test, using a significance level of 0.05.
